Total Payments
$4,724
2024 Payments
$1,473
Companies
25
Transactions
159
Medicare Patients
4,452
Medicare Billing
$424,455
Payment Breakdown by Category
Food & Beverage$4,557 (96.5%)
Education$167.26 (3.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,557 | 156 | 96.5% |
| Education | $167.26 | 3 | 3.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,376 | 39 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $419.52 | 6 | $0 (2024) |
| Lilly USA, LLC | $363.45 | 10 | $0 (2024) |
| PFIZER INC. | $362.13 | 16 | $0 (2024) |
| Janssen Biotech, Inc. | $332.53 | 14 | $0 (2024) |
| GENZYME CORPORATION | $282.38 | 13 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $186.24 | 9 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $179.20 | 5 | $0 (2024) |
| UCB, Inc. | $152.79 | 8 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $121.00 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,473 | 58 | E.R. Squibb & Sons, L.L.C. ($278.89) |
| 2023 | $941.38 | 36 | Janssen Biotech, Inc. ($150.71) |
| 2022 | $916.45 | 32 | ABBVIE INC. ($305.35) |
| 2021 | $345.65 | 17 | AbbVie Inc. ($114.15) |
| 2020 | $176.64 | 5 | Lilly USA, LLC ($110.37) |
| 2019 | $780.24 | 10 | AbbVie, Inc. ($584.17) |
| 2018 | $90.25 | 1 | Lilly USA, LLC ($90.25) |
All Payment Transactions
159 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $8.16 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: Immunology | ||||||
| 12/04/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $115.20 | General |
| Category: Immunology | ||||||
| 12/03/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: Dermatology | ||||||
| 11/20/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $11.49 | General |
| Category: Dermatology | ||||||
| 11/18/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $19.94 | General |
| Category: Dermatology | ||||||
| 11/12/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $24.28 | General |
| Category: Immunology | ||||||
| 11/11/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: Immunology | ||||||
| 11/04/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $24.80 | General |
| Category: Immunology | ||||||
| 10/07/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: Immunology | ||||||
| 10/01/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: Dermatology | ||||||
| 09/16/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: Immunology | ||||||
| 09/16/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $12.31 | General |
| Category: Dermatology | ||||||
| 09/04/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $17.43 | General |
| 09/03/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.40 | General |
| Category: IMMUNOLOGY | ||||||
| 08/27/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: IMMUNOLOGY | ||||||
| 08/20/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $25.25 | General |
| Category: Dermatology | ||||||
| 08/13/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $27.40 | General |
| Category: DERMATOLOGY | ||||||
| 08/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $24.29 | General |
| Category: Immunology | ||||||
| 08/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: IMMUNOLOGY | ||||||
| 08/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: Immunology | ||||||
| 07/29/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $27.91 | General |
| Category: Dermatology | ||||||
| 07/29/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $4.94 | General |
| Category: Immunology | ||||||
| 07/23/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 2,253 | 4,515 | $766,081 | $212,853 |
| 2022 | 24 | 1,811 | 3,444 | $620,693 | $177,297 |
| 2021 | 11 | 388 | 625 | $104,785 | $34,305 |
Total Patients
4,452
Total Services
8,584
Medicare Billing
$424,455
Procedure Codes
58
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 275 | 487 | $117,367 | $42,667 | 36.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 282 | 366 | $62,952 | $24,022 | 38.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 251 | 347 | $54,132 | $21,684 | 40.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 312 | 457 | $86,830 | $15,685 | 18.1% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 63 | 71 | $42,813 | $13,730 | 32.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 114 | 114 | $45,828 | $12,264 | 26.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 119 | 150 | $30,000 | $11,215 | 37.4% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 25 | 27 | $32,562 | $9,955 | 30.6% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 125 | 240 | $22,320 | $9,210 | 41.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 242 | 1,646 | $72,424 | $8,079 | 11.2% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 58 | 71 | $26,270 | $7,597 | 28.9% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 60 | 78 | $42,120 | $7,401 | 17.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 108 | 108 | $30,780 | $7,197 | 23.4% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 33 | 43 | $26,058 | $5,158 | 19.8% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 14 | 15 | $14,010 | $4,464 | 31.9% |
| 11622 | Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 24 | 26 | $15,444 | $3,051 | 19.8% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 18 | 19 | $7,638 | $2,423 | 31.7% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 18 | 20 | $12,020 | $2,292 | 19.1% |
| 69100 | Biopsy of ear | Office | 2023 | 27 | 32 | $8,096 | $1,453 | 17.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 36 | 40 | $4,400 | $1,448 | 32.9% |
| 11642 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 12 | 13 | $9,360 | $1,358 | 14.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 18 | 42 | $2,142 | $425.10 | 19.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 19 | 103 | $515.00 | $75.17 | 14.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 194 | 316 | $76,156 | $29,506 | 38.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 229 | 290 | $49,880 | $19,639 | 39.4% |
About Dr. Alexander Davis, MD
Dr. Alexander Davis, MD is a Dermatology healthcare provider based in Panama City, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/03/2017. The National Provider Identifier (NPI) number assigned to this provider is 1285160879.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alexander Davis, MD has received a total of $4,724 in payments from pharmaceutical and medical device companies, with $1,473 received in 2024. These payments were reported across 159 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($4,557).
As a Medicare-enrolled provider, Davis has provided services to 4,452 Medicare beneficiaries, totaling 8,584 services with total Medicare billing of $424,455. Data is available for 3 years (2021–2023), covering 58 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Panama City, FL
- Active Since 05/03/2017
- Last Updated 01/12/2022
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1285160879
Products in Payments
- DUPIXENT (Biological) $483.37
- RINVOQ (Biological) $476.56
- TREMFYA (Drug) $316.61
- Sotyktu (Drug) $305.35
- TALTZ (Drug) $295.15
- Humira (Biological) $255.12
- EUCRISA (Drug) $252.34
- Skyrizi (Biological) $250.93
- SKYRIZI (Biological) $208.13
- ORACEA (Drug) $119.14
- Bimzelx (Biological) $101.79
- SPEVIGO (Drug) $97.89
- OPZELURA (Drug) $95.95
- Otezla (Drug) $85.55
- ILUMYA (Biological) $69.03
- ADBRY (Biological) $65.33
- COSENTYX (Drug) $64.24
- COSENTYX (Biological) $60.39
- Cimzia (Drug) $51.00
- Erivedge (Biological) $49.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Panama City
Dr. Jon Ward, Md, MD
Dermatology — Payments: $15,137
Dermatology $15,137
Charles Kovaleski, Md, MD
Dermatology — Payments: $10,075
Dermatology $10,075
Robert Siragusa, Md, MD
Dermatology — Payments: $8,886
Dermatology $8,886
Dr. Christopher Wolfe, Do, DO
Dermatology — Payments: $2,755
Dermatology $2,755